Influence of MiRNAs in gestational diabetes mellitus development.

Ginekologia polska
Ilona Juchnicka, Mariusz Kuzmicki

Abstract

Gestational Diabetes Mellitus (GDM) is a metabolic disorder that is considered a prediabetes state. According to the International Diabetes Federation every year an increase in the number of women diagnosed with gestational diabetes is being noticed. It is known that GDM can cause many complications during pregnancy and labor. What is more, women with GDM history and their offspring are at risk of developing diabetes in the future. A new factor in the pathogenesis of GDM is epigenetics, which is described as changes in gene expression without directly modifying the DNA sequence. One of its regulating mechanisms is based on microRNA (miRNA). A small non-coding RNA sequence that has an influence on protein formation by suppressing gene expression. A better understanding of the miRNA's function could potentially lead to their usage as potential new biomarkers or treatment targets. In this article we review the most significant miRNA molecules in gestational diabetes.

Related Concepts

Related Feeds

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.

Related Papers

The Medical Journal of Australia
L Hoffman
Asia Pacific Journal of Clinical Nutrition
B H Hsu-Hage, X Yang
Vnitr̆ní lékar̆ství
M Kvapil, D Bartásková
BJOG : an International Journal of Obstetrics and Gynaecology
Christina Scifres
World Journal of Diabetes
Ulla KampmannPer Ovesen
© 2021 Meta ULC. All rights reserved